viagra prescription
blindness cialis
viagra wholesale
levitra tablets
cialis prescription
cialis online order
viagra use
levitra alternative
cialis com
cialis europe viagra
cialis uk
viagra online pharmacy
viagra for woman
cialis commercial
cialis testimonials
20mg cialis
cheap generic viagra
generic tadalafil
viagra sample
order viagra
cialis generic viagra
cialis discount
levitra for sale
cialis order
purchase viagra online
tadalafil citrate
online levitra
cialis viagra vs
viagra sales uk
viagra canada
cialis versus viagra
cialis company
viagra commercial
cialis pill
cialis tadalafil
viagra dosage
cialis lowest price
levitra buy
cialis woman
buy viagra
affordable viagra
viagra trial
cialis vs viagra
levitra safe
swine influenza
viagra soft tab
effects of viagra
levitra vs viagra
low cost viagra
cialis mt
levitra purchase
discount viagra online
cialis generic price
cialis review
mail order viagra
cialis generic
cialis generic online
viagra vs cialis
oseltamivir
levitra cheap
levitra
levitra mg
cialis liquid
viagra pill
save on drugs viagra
offender viagra
canada cialis generic
cialis get viagra
levitra online
cheap viagra online
cialis lilly
penisole
cialis soft
cialis sample
levitra order
apotheke cialis
discount levitra
purchase viagra
levitra pills
where to buy levitra
viagra mexico
viagra cialis levitra
cialis why
viagra 50mg
cialis professional
cheap viagra uk
cialis soft tab
cheap cialis
cialis from india
cialis discount generic
cialis soft tabs
cialis discount online
viagra price
cialis open western
viagra online
herbal viagra
levitra dosage
buying viagra
cialis levitra vs
levitra canada
viagra for sale
save on pills
levitra sales
cialis compare viagra
penis growth oil
cialis viagra
order viagra online
pfizer viagra
100mg viagra
discount viagra
cialis levitra
viagra professional
cialis mt tadalafil
levitra drug
cialis europe get
viagra levitra
viagra shop
buy generic viagra
lowest viagra price
viagra substitute
cialis pharmacy
penis extender
viagra sales
cialis price
best price viagra
how viagra works
canada cialis
cialis jelly
viagra information
how does viagra work
cialis online
cialis drug
natural viagra
cialis new viagra
trial viagra
cialis mexican
cheap viagra
cialis effects side
citrate sildenafil
drug viagra
womens viagra
generic levitra
viagra and alcohol
cialis tablet
save on drugs
levitra cost
viagra erection
viagra story
viagra sale
viagra jelly
cialis levitra viagra
woman taking viagra
buying viagra online
viagra soft tabs
medicaid viagra
cialis uprima viagra
viagra side effects
best cialis price
viagra pharmacy
generic viagra
cheap cialis generic
buy cheap cialis
comprare cialis
comprare viagra
cheapest cialis
viagra cialis
viagra research
get viagra
viagra alternative
cialis online pharmacy
cialis compare levitra
generic viagra online
female viagra
cialis purchase
cheapest viagra
cialis online purchase
cialis dosage
cialis experience
canadian cialis
viagra sale online
cialis germany
levitra price
viagra on line
levitra prescription
cialis mexico
cialis sale
where to buy viagra
viagra soft
how levitra works
levitra professional
buy cialis
viagra uk
free porn

Attendees at Hedge Funds World Zurich wonder: Should risk models now anticipate the “statistically impossible”?

Dec 4th, 2008 | Filed under: Today's Post

AllAboutAlpha.com contributor Timothy Laing reports today from The Dolder Grand hotel, over looking Zurich on this week’s Hedge Funds World Zurich conference…

“How many of you think the Sharpe Ratio is bull****?”

With characteristic bluster, author Nassim Nicholas Taleb addressed the audience of hedge funds, investors and service providers assembled before him earlier this week in Zurich (Hedge Funds World Zurich). Overall, it’s safe to say that Taleb doesn’t like quants.  He says he prefers to keep things “as simple as possible“, to plan, and to wait patiently for an unlikely, yet inevitable turn of events (i.e. the storied “Black Swan”).  But unfortunately, this is not a typical strategy in the financial markets.  Prop desk traders do not get paid to wait; pension funds cannot go 90% cash and 10% options; and hedge funds managers do not get paid to “keep things simple”.

Taleb is an options trader - or to be more precise, an options buyer.  Since the investing public often has a tough time with the concept of short selling, Taleb’s strategy might seem complex - but it’s not.

Essentially, he buys cheap insurance on all sorts of things (many, many, things) pays monthly premiums and - like a hunter - waits for Black Swans. He firmly believes that Black Swans are more plentiful than option sellers realize. Thus, he figures that the playing field is tilted in his favor. In the meantime, he ends up providing liquidity to capital markets.

Naturally, he also had a lot to say on the subject of risk management/measurement - arguing that “stress testing is useless since it tests the past and not the possible” and that “the 1,000 year flood cannot be seen in 100 years of data”. In addition to his critique of Sharpe, he went on to fire well aimed shots at VaR, portfolio theory, and the people who use these tools. He says simply that classic statistical tools do not apply to financial markets.

Taleb is a commensurate salesman. He and his colleagues know that most people do not have the ability to execute his strategies on their own, and that Wall Street’s bonus system keeps the competition out of their trades.  His stories are full of the kinds of colourful anecdotes that experienced traders love to relate.  He likes to shock his audience and is no stranger to the colourful language synonymous with successful traders. He is clearly one of the smartest guys in the room. If only Enron or LTCM had hired Taleb, history may have unfolded differently.

But at a major hedge funds conference, especially one in Switzerland, you expect to meet smart people like Taleb.   Gerlof de Vrij, Head of Global Tactical Asset Allocation at Dutch government pension fund APG Investments, is another one these.

de Vrij told the audience that “we are experiencing a flight to simplicity“.  He doesn’t think much of structured products or hedge fund replication, and believes that while you may be able to replicate the details you cannot replicate “the intelligence”. During a panel discussion on Wednesday, he accused many hedge fund managers of being too beta-oriented (i.e. long-only “closet-indexers”), and said that investors with appropriate capacity and infrastructure could simply trade many of these strategies themselves. Taleb would probably agree.

There was considerable discussion surrounding fees, lock ups, and gates at this year’s event. The common feeling was that lock ups and gates should be strategy dependent. Lock-ups for a managed futures fund would be a tough sell, for example. But a distressed fund could more easily make an argument for such a provision.

At the same time, many felt that fees should better reflect the new manager/investor relationship.  Kerrin Rosenberg, CEO of Cardano UK, suggested that “1 & 10″ might be a fair fee for an investor who agreed to a two year lock up, but “2 & 20″ was more suitable for an investor requiring immediate liquidity (or, as Rosenberg put it, an investor “who may panic at the wrong time”). He also made the point that the management fee should only serve to cover fixed costs and is therefore too high for most large funds (who require much less to keep the lights on).

At conferences like this, it’s often difficult to maintain audience attention during sessions on hedge fund regulation. Patrice Berge-Vincent of the French regulator, Autorité des marchés financiers, gave it a good college try.  However, in this blogger’s opinion, Gerlof de Vrij’s “flight to simplicity” seems to have bypassed Paris’ Charles de Gaulle airport.   Indeed, it often seems that regulators are embracing greater complexity, just as investors are demanding more simplicity.

The recent market calamities may have placed an elephant in the room here in Zurich. Many wondered how - or even if - risk management models should hereinafter reflect what has recently occurred. Michael Brandenberger, CEO of Complementa Investment Controlling, was asked how he would adjust risk management systems in light of recent events. His answer sums it all up:

“What happened to HFs over the past few months was not statistically possible so it is going to be difficult to adjust risk management models to reflect what has happened.”

You could hear Taleb smiling.

Timothy Laing, CFA, CAIA is Head of Business Development at Plenum Investments in Zurich.  The opinions expressed in this guest contribution are those of the author and not necessarily those of AllAboutAlpha.com.

Leave Comment